TWD 26.9
(0.94%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -214.69 Million TWD | -0.27% |
2022 | -211.39 Million TWD | -66.04% |
2021 | -127.31 Million TWD | 21.47% |
2020 | -162.12 Million TWD | 0.69% |
2019 | -163.24 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -37.73 Million TWD | 0.0% |
2024 Q1 | -37.73 Million TWD | 33.16% |
2023 Q2 | -50.89 Million TWD | 0.0% |
2023 FY | -211.96 Million TWD | -0.27% |
2023 Q3 | -56.45 Million TWD | -10.92% |
2023 Q1 | -50.89 Million TWD | 7.09% |
2023 Q4 | -56.45 Million TWD | 0.0% |
2022 Q3 | -54.77 Million TWD | 0.0% |
2022 FY | -211.39 Million TWD | -66.04% |
2022 Q4 | -54.77 Million TWD | 0.0% |
2021 FY | -127.31 Million TWD | 21.47% |
2020 FY | -162.12 Million TWD | 0.69% |
2019 FY | -163.24 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Bio Preventive Medicine Corp. | -70.58 Million TWD | -204.178% |
Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -152.6% |
Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -130.024% |
Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | -1.174% |
NaviFUS Corp. | -76.42 Million TWD | -180.919% |
G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 366.094% |
Sinew Pharma Inc. | -186.25 Million TWD | -15.271% |
Lin BioScience, Inc. | -1.09 Billion TWD | 80.426% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -3148.033% |
Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 42.843% |
Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -278.324% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 176.173% |
AP Biosciences Inc | -347.47 Million TWD | 38.213% |
Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 123.994% |
RBC Bioscience Corporation | 14.53 Million TWD | 1576.683% |
Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 164.264% |
EirGenix Inc. | -1.03 Billion TWD | 79.196% |
Enimmune corporation | -243.47 Million TWD | 11.821% |
Lukas Biomedical Inc. | -43.56 Million TWD | -392.872% |
BRIM Biotechnology, Inc. | -694.12 Million TWD | 69.07% |
3D Global Biotech Inc. | -62.85 Million TWD | -241.583% |
TaiMed Biologics Inc. | -166.23 Million TWD | -29.155% |
Mycenax Biotech Inc. | -602.1 Million TWD | 64.342% |
TCI GENE Inc. | 10.04 Million TWD | 2236.481% |
SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -371.836% |
Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 80.422% |
Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -417.562% |
Feng Chi Biotech Corp. | 24.16 Million TWD | 988.565% |
NeoCore Technology Co., Ltd. | -84.94 Million TWD | -152.749% |
TWi Biotechnology, Inc. | -169.55 Million TWD | -26.622% |
Neith Corporation | -48.85 Million TWD | -339.462% |
Sunny Pharmtech Inc. | -72.09 Million TWD | -197.79% |
VBI | -16.13 Million TWD | -1230.864% |
Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 163.57% |
GeneReach Biotechnology Corp. | -229.28 Million TWD | 6.363% |
Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -242.509% |
CHO Pharma, Inc. | -268.99 Million TWD | 20.187% |
Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -217.141% |
MegaPro Biomedical Co., Ltd | -127.25 Million TWD | -68.71% |
Visgeneer Inc. | -21.15 Million TWD | -914.675% |
Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 234.338% |
BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 438.983% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -128.508% |
Sagittarius Life Science Corp | -64.37 Million TWD | -233.502% |
BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | -21.612% |
GlycoNex Incorporation | -259.86 Million TWD | 17.382% |
Medigen Biotechnology Corp. | -1.23 Billion TWD | 82.589% |
Pharmosa Biopharm Inc. | -2.82 Million TWD | -7502.514% |
PharmaEngine, Inc. | 277.18 Million TWD | 177.456% |
Intech Biopharm Corporation | -304.39 Million TWD | 29.469% |
Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -9429.294% |
BiOptic Inc. | 44.05 Million TWD | 587.356% |
TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | -22.894% |
Senhwa Biosciences, Inc. | -311.11 Million TWD | 30.991% |
NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 6352.038% |
OBI Pharma, Inc. | -2.08 Billion TWD | 89.726% |
Savior Lifetec Corporation | -2.42 Million TWD | -8771.694% |
Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -226.185% |
Level Biotechnology Inc. | 67.55 Million TWD | 417.822% |
Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 82.313% |
Meribank Biotech Co., Ltd | -123.15 Million TWD | -74.331% |
Acepodia, Inc. | -435.97 Million TWD | 50.755% |
Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 56.001% |